Wenhao Xu

21PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 07, 2026
APOE+ macrophages and POSTN+CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma.

|Jul 12, 2026
METTL5-mediated rRNA modification controls prostate cancer progression through the IRF7/DNA2 axis and mitophagy regulation.

|Jun 01, 2026
APOL3 Orchestrates Metastasis and Enzalutamide Resistance via STAT3-DAB2IP Signaling in Prostate Cancer.

|May 21, 2026
Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical Therapies.

|Nov 27, 2025
Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF-κB and TGF-β Signaling Pathways.

Shiqi Ye, Jianfeng Xiang, Siqi Zhou

|Jun 27, 2025
Regulatory B cells promote the immunosuppressive microenvironment and progression of clear cell renal cell carcinoma.

Qintao Ge, Siqi Zhou, Jiahe Lu

Pageof 4

Frequent Collaborators

4 joint publications

Wangrui Liu

4 joint publications

Dingwei Ye

3 joint publications

Xi Tian

3 joint publications

Dingwei Ye